| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $205.1M | — | +9.5% |
| Cost of Revenue | $25.4M | — | +32.2% |
| Gross Profit | $179.7M | — | +6.9% |
| R&D Expense | $66.1M | — | -12.0% |
| SG&A Expense | $36.4M | — | -1.6% |
| Operating Income | -$15.2M | — | +65.3% |
| Pre-tax Income | -$13.0M | — |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $193.7M | -3.1% | -0.1% |
| Accounts Receivable | $73.5M | -33.4% | +7.9% |
| Current Assets | $550.5M | -7.2% | -6.5% |
| Total Assets | $805.5M | -4.6% | -8.2% |
| Current Liabilities | $479.6M | -4.3% | +20.1% |
| Total Liabilities |
| Line Item | 2026-04-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $40.2M | — | +495.0% |
| Capital Expenditures | $2.8M | — | +340.1% |
| Investing Cash Flow | -$3.4M | — | -181.9% |
| Financing Cash Flow | -$41.9M | — | -659.1% |
| Free Cash Flow | $37.4M | — | +511.1% |
| +66.6% |
| Income Tax | $1.4M | — | +23.1% |
| Net Income | -$14.4M | — | +64.0% |
| EPS (Basic) | -$0.06 | — | +64.7% |
| EPS (Diluted) | -$0.06 | — | +64.7% |
| $668.5M |
| -3.1% |
| +4.3% |
| Stockholders' Equity | $137.0M | -11.1% | -42.0% |